BiotechTube
Home/KaliVir Immunotherapeutics/Paul Youm
PY

Paul Youm

Vice President, Corporate Development and Alliance Management

KaliVir Immunotherapeutics

Therapeutic Areas

Oncology

KaliVir Immunotherapeutics Pipeline

DrugIndicationPhase
VET3-TGIAdvanced Solid TumorsPhase 1

Leadership Team at KaliVir Immunotherapeutics

JM
James M. Burke, M.D.
Chief Medical Officer
UF
Ursula Fritsch, PharmD
Chief Regulatory Officer
SG
Schond Greenway
Chief Financial Officer
AP
Adina Pelusio
Chief Development Officer
View full KaliVir Immunotherapeutics profile